secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-07-10T23:59:59+00:00
Accession:  0001641172-25-018553
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics raises $4.6M via warrant exercise at $0.70/share
-----------------------------------------------------------------------

- Gross proceeds ~$4.6M from immediate exercise of 6,595,000 warrants at $0.70/share.
- New Series H warrants issued for up to 6,595,000 shares at $0.70, exercisable after 6 months.
- 7 warrant holders participated; closing expected July 10, 2025.
- Net proceeds for clinical programs and working capital.
- Ladenburg Thalmann acts as placement agent with 8% fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/0001641172-25-018553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225018553/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer